Correlations between MRI biomarkers PDFF and cT1 with histopathological features of non-alcoholic steatohepatitis

<p><strong>Introduction</strong></p> Late stage clinical trials in non-alcoholic steatohepatitis (NASH) are currently required by the FDA to use a liver biopsy as a primary endpoint. The well reported limitations with biopsy, such as associated risks and sampling error, coupl...

Full description

Bibliographic Details
Main Authors: Dennis, A, Kelly, MD, Fernandes, C, Mouchti, S, Fallowfield, JA, Hirschfield, G, Pavlides, M, Harrison, S, Chakravarthy, MV, Banerjee, R, Sanyal, A
Format: Journal article
Language:English
Published: Frontiers Media 2021